NDC 0641-6022-01 - Famotidine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0641-6022
- Requested NDC
- 0641-6022-01
- Package NDCs from labels
- 0641-6022-01, 0641-6022-25
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Effective date
- 2024-04-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Famotidine Injection, USP | Hikma Pharmaceuticals USA Inc. | 2024-04-09 | HUMAN PRESCRIPTION DRUG LABEL |
| Famotidine - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-08 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6022-01 | Famotidine | 2 mL in 1 VIAL | INJECTION | 2 | 9 | |
| 0641-6022-25 | Famotidine | 25 in 1 CARTON | INJECTION | 25 | 9 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6022-01 | ML - Milliliter | 0641-6022 | 14529626-4b70-42c6-a890-9b69073ec03a | 1 | 2013-02-13 |
| 0641-6022-25 | ML - Milliliter | 0641-6022 | 4387b354-0e9e-4478-9b06-72f87bf78c58 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FAMOTIDINE | ACTIVE INGREDIENT | 5QZO15J2Z8 | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| FAMOTIDINE | ACTIVE MOIETY | 5QZO15J2Z8 | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| ASPARTIC ACID | INACTIVE INGREDIENT | 30KYC7MIAI | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| BENZYL ALCOHOL | INACTIVE INGREDIENT | LKG8494WBH | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | FAMOTIDINE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| dg health heartburn prevention | FAMOTIDINE | Dolgencorp Inc | a8383769-ce8b-43eb-b1a6-5d73e7fcf30d | 2022-06-07 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Mylan Institutional LLC | e3b13e23-122b-4bd4-95cf-b5a14b7afc05 | 2022-06-01 | Warnings, Adverse reactions | 204441 1743833 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Proficient Rx LP | 68120de1-fd9a-4f93-b218-d99ed7c5080a | 2022-06-01 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Proficient Rx LP | 9baf2596-b771-4bae-a03c-d3af6716821d | 2022-05-02 | Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Proficient Rx LP | 787724dc-0b4b-4973-852e-c7d722f637b0 | 2022-05-01 | Warnings | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Akorn | 354a5a02-45cb-4ab0-88ee-6635d5a43b01 | 2022-03-10 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | Ascent Pharmaceuticals, Inc. | b481dd30-7d64-43ec-85d4-2289db62cad7 | 2022-02-14 | Warnings | 5QZO15J2Z8 |
| Sterile Water | WATER | American Regent, Inc. | 78b35864-4bbc-4759-a5c1-7e4f25e22932 | 2022-01-31 | Boxed warning | 059QF0KO0R |
| basic care acid reducer | FAMOTIDINE | Amazon.com Services LLC | 94fbcebe-7d75-47c1-9eca-cfa9b952a3d5 | 2022-01-06 | Warnings | 5QZO15J2Z8 |
| Sterile Diluent for Treprostinil | WATER | Dr.Reddy's Laboratories Inc., | 33050ee2-519b-1f0b-d4df-9e14dd329c57 | 2021-12-23 | Warnings, Adverse reactions | 059QF0KO0R |
| FAMOTIDINE | FAMOTIDINE | XLCare Pharmaceuticals, Inc. | 7b550cf9-221f-4f28-ba99-414ad7d5612f | 2021-12-10 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Camber Pharmaceuticals, Inc. | 902b5d4b-1707-4312-9f46-ef5ab86b00f0 | 2021-11-19 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | Amneal Pharmaceuticals NY LLC | bb602b05-0ce6-4029-bd6e-291076e64efb | 2021-08-30 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Sterile Water | STERILE WATER | B. Braun Medical Inc. | d99f9133-e4d0-4dee-b611-dbc3f918b547 | 2021-08-09 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | B. Braun Medical Inc. | 8924e52e-8622-4ed6-a061-1908183e0a18 | 2021-08-06 | Warnings, Adverse reactions | 059QF0KO0R |
| Famotidine | FAMOTIDINE | Fresenius Kabi USA, LLC | ce533636-cc9b-45d0-87a6-5390377ff28a | 2021-07-15 | Warnings, Adverse reactions | 1743833 5QZO15J2Z8 |
| Eyewash | EYEWASH | Global Equipment Company | c4f78121-4668-2e0c-e053-2995a90ab6c6 | 2021-06-17 | Warnings | 059QF0KO0R |
| Famotidine | FAMOTIDINE | Aphena Pharma Solutions - Tennessee, LLC | 46c6d243-eefc-40ca-8bd4-4c89456f635f | 2021-05-18 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Famotidine | FAMOTIDINE | BluePoint Laboratories | 8c7ca3cc-ff90-42a7-9218-554cf15348a3 | 2021-04-13 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Sterile Water | WATER | Asclemed USA, Inc. | 45c38269-883c-4198-a9d5-03810a4420ec | 2021-01-14 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.